Aminex PLC (LON:AEX)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 55.88M -28.4% |
| Revenue (ttm) | 36.41K +25.6% |
| Net Income | -3.70M |
| EPS | -0.00 |
| Shares Out | 4.47B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 440,324 |
| Open | 1.299 |
| Previous Close | 1.250 |
| Day's Range | 1.299 - 1.300 |
| 52-Week Range | 1.000 - 2.900 |
| Beta | -0.30 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 26, 2026 |
About Aminex
Aminex PLC, together with its subsidiaries, engages in the exploration, appraisal, development, and production of oil and gas assets, reserves, and resources. It operates through Producing Oil and Gas Properties, Exploration Activities, and Oilfield Services segments. The company’s flagship properties include the Ruvuma PSA located primarily in Tanzania. Aminex PLC was incorporated in 1979 and is based in Dublin, Ireland. [Read more]
Financial Performance
In 2025, Aminex's revenue was $49,000, an increase of 25.64% compared to the previous year's $39,000. Losses were -$4.98 million, -6.00% less than in 2024.
Financial numbers in USD Financial StatementsNews
Aminex: A New Direction in Oncology Emerges from Years of Polyamine Research
Families facing aggressive cancers often find themselves navigating therapies that can be physically demanding, particularly when standard treatments are rendered futile.